REBECCA ELIZABETH GANZON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health PICKERINGTON, OH NPI 1528554235

General Payments — all program years on this page

$22,570.39

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 58
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,442.80 across 5 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Deciphera Pharmaceuticals Inc. $1,232.503
Amgen Inc. $111.741
Janssen Biotech, Inc. $98.561

By program year

Program yearAmountRecords
2021 $6,445.0011
2022 $6,423.8512
2023 $8,258.7430
2024 $1,442.805

Records — PY2024 (5)

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.